Clinical Trials Logo

Filter by:
NCT ID: NCT05194514 Active, not recruiting - Organ Transplant Clinical Trials

Trial to Compare the SherpaPak™ Device vs Cold Storage

SherpaPak
Start date: May 11, 2022
Phase: N/A
Study type: Interventional

The Investigator's are doing this study to see which method of organ preservation leads to better outcomes for donated hearts. There are two methods of organ preservation. The first method is the use of cold storage. With this method, the donor heart is stored in preservation fluid within bags that are then placed on ice and transported in a cooler. This is the usual method for transporting donor hearts. This is also known as "standard of care." The second method is the use of the SherpaPak™ Cardiac Transport System. With this method, the donor heart is kept at a steady, consistent temperature throughout transportation. This method is not typically used for transporting donor hearts. The study will include up to 20 people in total.

NCT ID: NCT05194410 Active, not recruiting - Exercise Clinical Trials

The Effect of Community Building Through Virtual, Team-Based Exercise on Burnout

MedMotion
Start date: July 18, 2021
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial that will look at whether virtual, team-based exercise improves burnout, sense of community, and mentorship connections among medical students, residents, fellows, and physicians.

NCT ID: NCT05194345 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

An Integrated Nutrition Intervention to Promote Healthy Eating Habits for Children With ASD

Start date: January 27, 2022
Phase: N/A
Study type: Interventional

There is an unmet need for nutrition interventions that address both autism spectrum disorder (ASD) specific feeding challenges and unbalanced eating habits among children with ASD to prevent future chronic health conditions. Children with ASD tend to consume few fruit and vegetables and mainly high-energy dense foods, including sugar-sweetened beverages and processed snacks. Obesity prevalence in children with ASD is up to 40% higher than in typically developing children, and recent studies show significantly elevated risks of hyperlipidemia and hypertension among individuals with ASD, regardless of using psychotropic medications. Our interdisciplinary team conducted a preliminary study to examine diet quality and mealtime behaviors among diverse children with ASD in Florida (34% Hispanic/Latino) and parental preferences for nutrition interventions. Based on the study findings, we developed the manual for our nutrition intervention, Autism Eats, for children with ASD enrolled in the Part C of Individuals with Disabilities Education Act (IDEA) Early Intervention (EI) services. Our Autism Eats manual and parent materials are based on ASD-specific feeding strategies such as food chaining combined with behaviorally-focused nutrition intervention strategies such as goal setting and weekly meal planning to promote healthy eating. Among children with ASD enrolled in Part C EI services in Florida, we will conduct a randomized controlled trial (RCT) with the nutrition intervention program, Autism Eats, and the enhanced usual care (EUC) comparison program. The Autism Eats intervention is to prevent problematic mealtime behaviors and promote development of healthy eating habits. We expect that implementing the Autism Eats will be feasible and the intervention will be well-received by EI providers and parent-child dyads. We will examine differences in children's food intakes (fruit and vegetables), food variety, diet quality, and problematic mealtime behaviors between children in Autism Eats and those in the EUC groups at post-intervention and 5-month follow-up from baseline.

NCT ID: NCT05193500 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Study 3 Learning Verbs and Pronouns

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The goal of this research is to explore abilities to learn word meanings from overheard conversations in children with ASD (and, as a control, typically developing children). Specific Aim 3 (Experiment 3): Determine whether children with ASD can learn verbs and pronouns by overhearing. Most prior work on learning from overheard speech has focused on learning nouns that label objects. This experiment extends this work to study other kinds of words.

NCT ID: NCT05192954 Active, not recruiting - Clinical trials for Pelvic Organ Prolapse

Comparing Postoperative Pain After Vessel Sealing Device Versus Conventional Suturing Methods for Vaginal Hysterectomy and Pelvic Reconstructive Surgery

Start date: January 28, 2022
Phase: N/A
Study type: Interventional

This study will investigate pain outcomes for patients undergoing vaginal hysterectomy with pelvic reconstructive surgery using the LigasureTM vessel sealing device as compared to conventional clamping and suturing methods.

NCT ID: NCT05192889 Active, not recruiting - Clinical trials for Refractory Acute Lymphoblastic Leukemia

Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

Start date: August 25, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase I/II clinical trial evaluating the activity of combination chemotherapy with venetoclax and navitoclax in children with relapsed or refractory acute lymphoblastic leukemia or lymphoma (rALL) and assessing the combination dose of venetoclax combinations with either blinatumomab for CD19-postive patients or navitoclax and high-dose cytarabine for CD19-negative patients. Primary Objectives - To compare Minimal Residual Disease (MRD)-negative CR/CRi rate in children with relapsed or refractory acute lymphoblastic leukemia or lymphoma (rALL) following Block 1 therapy with venetoclax and navitoclax based reinduction to historical controls. - To identify the recommended phase 2 combination dose (RP2D) of venetoclax based consolidation in novel combinations with a) high-dose cytarabine and navitoclax or b) blinatumomab. Secondary Objectives - To estimate the tolerability and activity of venetoclax based consolidation in novel combinations with a) high-dose cytarabine and navitoclax or b) blinatumomab. - To describe event-free and overall survival in patients treated with this regimen. Exploratory Objectives - To evaluate MRD-negative CR/CRi rates in each prespecified groups: late first relapse B-ALL; early first relapse and second or greater relapse B-ALL; and relapsed T-ALL. - To identify drug sensitivity patterns in patient samples prior to and after receiving combination therapy and evaluate mechanisms of disease resistance/ escape. - To explore immune subsets during and after this regimen. - Evaluate response to therapy in rare relapse patient subsets. - Explore breakthrough infections in children and young adults with relapsed or refractory ALL

NCT ID: NCT05192850 Active, not recruiting - Clinical trials for Recurrent Endometrial Carcinoma

Endometrial Cancer Recurrence in Patients Taking Metformin

Start date: December 27, 2021
Phase:
Study type: Observational

Given the early literature available and its biological plausibility as an inhibitor of the mammalian target of rapamycin (mTOR) protein, it is hypothesized that women with endometrial cancer who take metformin for non-cancer related reasons have a lower cancer recurrence rate compared to women not taking metformin. The primary goal of this study is to determine whether metformin use is associated with a decrease in the rate of endometrial cancer recurrence. Secondary objectives are to assess whether women with endometrial cancer taking metformin have longer progression free survival and overall survival than those that do not take metformin.

NCT ID: NCT05192590 Active, not recruiting - Clinical trials for Cardiometabolic Syndrome

Establishing Clinical Utility Evidence for Chronic Disease Management Testing

Start date: October 22, 2021
Phase: N/A
Study type: Interventional

This is a national-level research study of primary care physicians. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.

NCT ID: NCT05192382 Active, not recruiting - Acromegaly Clinical Trials

A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)

PATHFNDR-2
Start date: December 17, 2021
Phase: Phase 3
Study type: Interventional

A randomized, placebo-controlled study designed to evaluate the safety and efficacy of paltusotine (formerly CRN00808; an oral selective nonpeptide somatostatin receptor type 2 biased agonist) in subjects with non-pharmacologically treated acromegaly.

NCT ID: NCT05192109 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Study 2: Learning New Words From Overhearing in Children With Autism Spectrum Disorder (ASD)

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The goal of this research is to explore abilities to learn word meanings from overheard conversations in children with ASD (and, as a control, typically developing children). Specific Aim 2 (Experiment 2): Determine whether children with ASD can learn from addressed and overheard teaching via videoconferencing. The investigators will use a similar procedure to Study 1, except that both overheard and directed teaching will take place on video.